Read + Share

Amedeo Smart

Independent Medical Education


Read + Share

Cloughesy T, Finocchiaro G, Belda-Iniesta C, Recht L, et al. Randomized, Double-Blind, Placebo-Controlled, Multicenter Phase II Study of Onartuzumab Plus Bevacizumab Versus Placebo Plus Bevacizumab in Patients With Recurrent Glioblastoma: Efficacy, Safety, and Hepatocyte Growth Factor and O6-Methylguanine-DNA M J Clin Oncol 2016 Dec 5:JCO2015647685.
PMID: 27918718


Free Medical Abstracts
Privacy Policy
Sponsors
Share
About

© Amedeo 1997-2016